These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24304875)

  • 1. Signalling: a new target for p53-null tumours.
    Lokody I
    Nat Rev Cancer; 2014 Jan; 14(1):8-9. PubMed ID: 24304875
    [No Abstract]   [Full Text] [Related]  

  • 2. Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors.
    Emerling BM; Hurov JB; Poulogiannis G; Tsukazawa KS; Choo-Wing R; Wulf GM; Bell EL; Shim HS; Lamia KA; Rameh LE; Bellinger G; Sasaki AT; Asara JM; Yuan X; Bullock A; Denicola GM; Song J; Brown V; Signoretti S; Cantley LC
    Cell; 2013 Nov; 155(4):844-57. PubMed ID: 24209622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transcription by p53 requires inositol polyphosphate multikinase as a co-activator.
    Xu R; Snyder SH
    Cell Cycle; 2013 Jun; 12(12):1819-20. PubMed ID: 23708509
    [No Abstract]   [Full Text] [Related]  

  • 4. PIP5K1A: a potential target for cancers with KRAS or TP53 mutations.
    East MP; Laitinen T; Asquith CRM
    Nat Rev Drug Discov; 2020 Jul; 19(7):436. PubMed ID: 32332925
    [No Abstract]   [Full Text] [Related]  

  • 5. Inositol polyphosphate multikinase is a coactivator of p53-mediated transcription and cell death.
    Xu R; Sen N; Paul BD; Snowman AM; Rao F; Vandiver MS; Xu J; Snyder SH
    Sci Signal; 2013 Apr; 6(269):ra22. PubMed ID: 23550211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-Dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene.
    Wang SJ; Yu G; Jiang L; Li T; Lin Q; Tang Y; Gu W
    Cell Cycle; 2013 Mar; 12(5):753-61. PubMed ID: 23343762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.
    Zhu W; Soonpaa MH; Chen H; Shen W; Payne RM; Liechty EA; Caldwell RL; Shou W; Field LJ
    Circulation; 2009 Jan; 119(1):99-106. PubMed ID: 19103993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and regulation of bioactive sphingolipids.
    Heffernan-Stroud LA; Obeid LM
    Adv Enzyme Regul; 2011; 51(1):219-28. PubMed ID: 21035490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nuclear phosphoinositide kinase complex regulates p53.
    Choi S; Chen M; Cryns VL; Anderson RA
    Nat Cell Biol; 2019 Apr; 21(4):462-475. PubMed ID: 30886346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 activates the PANK1/miRNA-107 gene leading to downregulation of CDK6 and p130 cell cycle proteins.
    Böhlig L; Friedrich M; Engeland K
    Nucleic Acids Res; 2011 Jan; 39(2):440-53. PubMed ID: 20833636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor twitter: cellular communication in the breast cancer stem cell niche.
    Brooks MD; Wicha MS
    Cancer Discov; 2015 May; 5(5):469-71. PubMed ID: 25941337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Vasculature Development in Zebrafish Embryos with Reduced Expression of Pantothenate Kinase 2 Gene.
    Khatri D; Mignani L; Zizioli D; Ritelli M; Monti E; Finazzi D
    Bull Exp Biol Med; 2020 Nov; 170(1):58-63. PubMed ID: 33237527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 and breast cancer, an update.
    Lacroix M; Toillon RA; Leclercq G
    Endocr Relat Cancer; 2006 Jun; 13(2):293-325. PubMed ID: 16728565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signalling enzymes: bursting with potential.
    Braselmann S; Palmer TM; Cook SJ
    Curr Biol; 1997 Aug; 7(8):R470-3. PubMed ID: 9259544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting sphingosine kinase 1 in cancer.
    Pyne NJ; Tonelli F; Lim KG; Long J; Edwards J; Pyne S
    Adv Biol Regul; 2012 Jan; 52(1):31-8. PubMed ID: 21791223
    [No Abstract]   [Full Text] [Related]  

  • 17. Discovery of AT gene sparks biomedical research bonanza.
    Nowak R
    Science; 1995 Jun; 268(5218):1700-1. PubMed ID: 7792589
    [No Abstract]   [Full Text] [Related]  

  • 18. Sphingosine-1-phosphate promotes expansion of cancer stem cells via S1PR3 by a ligand-independent Notch activation.
    Hirata N; Yamada S; Shoda T; Kurihara M; Sekino Y; Kanda Y
    Nat Commun; 2014 Sep; 5():4806. PubMed ID: 25254944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p21(WAF1/CIP1) response to genotoxic agents in wild-type TP53 expressing breast primary tumours.
    Guillot C; Falette N; Paperin MP; Courtois S; Gentil-Perret A; Treilleux I; Ozturk M; Puisieux A
    Oncogene; 1997 Jan; 14(1):45-52. PubMed ID: 9010231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT5A is regulated by DNA damage via the tumor suppressor p53.
    Mukhopadhyay UK; Cass J; Raptis L; Craig AW; Bourdeau V; Varma S; SenGupta S; Elliott BE; Ferbeyre G
    Cytokine; 2016 Jun; 82():70-9. PubMed ID: 26876578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.